{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:26:11Z","timestamp":1791012371396,"version":"4.1.0"},"reference-count":231,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:p>Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-\u03b3 (IFN-\u03b3) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-\u03b3 stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-\u03b3, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves\u2019 disease, Graves\u2019 ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison\u2019s disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.<\/jats:p>","DOI":"10.1210\/er.2006-0044","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T17:19:17Z","timestamp":1186507157000},"page":"492-520","source":"Crossref","is-referenced-by-count":215,"title":["Role of Chemokines in Endocrine Autoimmune Diseases"],"prefix":"10.1210","volume":"28","author":[{"given":"Mario","family":"Rotondi","sequence":"first","affiliation":[{"name":"Excellence Center for Research, Transfer and High Education De Novo Therapies, University of Florence, 50121 Florence, Italy"},{"name":"Unit of Internal Medicine and Endocrinology, Istituto Superiore per la Prevenzione e Sicurezza del Lavoro Laboratory for Endocrine Disruptors, Fondazione Salvatore Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Chair of Endocrinology, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Chiovato","sequence":"first","affiliation":[{"name":"Unit of Internal Medicine and Endocrinology, Istituto Superiore per la Prevenzione e Sicurezza del Lavoro Laboratory for Endocrine Disruptors, Fondazione Salvatore Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Chair of Endocrinology, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Romagnani","sequence":"first","affiliation":[{"name":"Excellence Center for Research, Transfer and High Education De Novo Therapies, University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Serio","sequence":"first","affiliation":[{"name":"Excellence Center for Research, Transfer and High Education De Novo Therapies, University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagnani","sequence":"first","affiliation":[{"name":"Excellence Center for Research, Transfer and High Education De Novo Therapies, University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071611552746000_R1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0049-3848(77)90117-7","article-title":"Primary structure of human platelet factor 4.","volume":"11","author":"Walz","year":"1977","journal-title":"Thromb Res"},{"key":"2020071611552746000_R2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"\u03b3-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"key":"2020071611552746000_R3","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1073\/pnas.85.11.3738","article-title":"Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties.","volume":"85","author":"Rollins","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611552746000_R4","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1073\/pnas.87.14.5238","article-title":"A macrophage mRNA selectively induced by \u03b3-interferon encodes a member of the platelet factor 4 family of cytokines.","volume":"87","author":"Farber","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611552746000_R5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.141.3.1018","article-title":"A human T cell-specific molecule is a member of a new gene family.","volume":"141","author":"Schall","year":"1988","journal-title":"J Immunol"},{"key":"2020071611552746000_R6","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.4049\/jimmunol.139.9.3126","article-title":"Cloning and characterization of a novel T cell activation gene.","volume":"139","author":"Burd","year":"1987","journal-title":"J Immunol"},{"key":"2020071611552746000_R7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0092-8674(83)90037-5","article-title":"Molecular cloning of gene sequences regulated by platelet-derived growth factor.","volume":"33","author":"Cochran","year":"1983","journal-title":"Cell"},{"key":"2020071611552746000_R8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1084\/jem.167.2.570","article-title":"Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.","volume":"167","author":"Wolpe","year":"1988","journal-title":"J Exp Med"},{"key":"2020071611552746000_R9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1096\/fasebj.3.14.2687068","article-title":"Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.","volume":"3","author":"Wolpe","year":"1989","journal-title":"FASEB J"},{"key":"2020071611552746000_R10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/1043-4666(91)90013-4","article-title":"Biology of the RANTES\/SIS cytokine family.","volume":"3","author":"Schall","year":"1991","journal-title":"Cytokine"},{"key":"2020071611552746000_R11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.09.040191.003153","article-title":"Properties of the novel proinflammatory supergene \u201cintercrine\u201d cytokine family.","volume":"9","author":"Oppenheim","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"2020071611552746000_R12","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","article-title":"Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.","volume":"84","author":"Yoshimura","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611552746000_R13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0006-291X(87)90432-3","article-title":"Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.","volume":"149","author":"Walz","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071611552746000_R14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.169.4.1485","article-title":"Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.","volume":"169","author":"Matsushima","year":"1989","journal-title":"J Exp Med"},{"key":"2020071611552746000_R15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-5793(89)80590-3","article-title":"Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.","volume":"244","author":"Yoshimura","year":"1989","journal-title":"FEBS Lett"},{"key":"2020071611552746000_R16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/347669a0","article-title":"Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.","volume":"347","author":"Schall","year":"1990","journal-title":"Nature"},{"key":"2020071611552746000_R17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.","volume":"179","author":"Jose","year":"1994","journal-title":"J Exp Med"},{"key":"2020071611552746000_R18","first-page":"24","article-title":"Nomenclature announcement: the chemokines.","volume":"14","author":"Lindley","year":"1993","journal-title":"Immunol Today"},{"key":"2020071611552746000_R19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1146\/annurev.immunol.22.012703.104543","article-title":"Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.","volume":"22","author":"Rot","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"2020071611552746000_R20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation.","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071611552746000_R21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity.","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"2020071611552746000_R22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2776(01)78002-9","article-title":"Chemokines in immunity.","volume":"78","author":"Yoshie","year":"2001","journal-title":"Adv Immunol"},{"key":"2020071611552746000_R23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines the regulatory link between inflammation and angiogenesis.","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol"},{"key":"2020071611552746000_R24","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071611552746000_R25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2004-831051","article-title":"Platelet factor 4: an inhibitor of angiogenesis.","volume":"30","author":"Bikfalvi","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"2020071611552746000_R26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer.","volume":"14","author":"Strieter","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"2020071611552746000_R27","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.","volume":"203","author":"Burns","year":"2006","journal-title":"J Exp Med"},{"key":"2020071611552746000_R28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1471-4906(03)00120-0","article-title":"Molecular evolution of CXC chemokines: extant CXC chemokines originate from the CNS.","volume":"24","author":"Huising","year":"2003","journal-title":"Trends Immunol"},{"key":"2020071611552746000_R29","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell \u03b1 chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"key":"2020071611552746000_R30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/geno.1995.9996","article-title":"Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.","volume":"29","author":"Marchese","year":"1995","journal-title":"Genomics"},{"key":"2020071611552746000_R31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes.","volume":"184","author":"Loetscher","year":"1996","journal-title":"J Exp Med"},{"key":"2020071611552746000_R32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"2020071611552746000_R33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.","volume":"187","author":"Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"2020071611552746000_R34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jlb.65.5.691","article-title":"Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo.","volume":"65","author":"Annunziato","year":"1999","journal-title":"J Leukoc Biol"},{"key":"2020071611552746000_R35","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.V10122518","article-title":"Role for interactions between IP-10\/Mig and their receptor (CXCR3) in proliferative glomerulonephritis.","volume":"10","author":"Romagnani","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2020071611552746000_R36","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3: activation of Ras\/ERK Src, and phosphatidylinositol 3-kinase\/Akt controls cell migration and proliferation in human vascular pericytes.","volume":"276","author":"Bonacchi","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071611552746000_R37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI9775","article-title":"Cell cycle dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.","volume":"107","author":"Romagnani","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"2020071611552746000_R39","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.","volume":"173","author":"Ehlert","year":"2004","journal-title":"J Immunol"},{"key":"2020071611552746000_R40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568008053174723","article-title":"CXCR3-binding chemokines: novel multifunctional therapeutic targets.","volume":"5","author":"Lazzeri","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"2020071611552746000_R41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm.","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol Today"},{"key":"2020071611552746000_R42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.02-0908fje","article-title":"Allergic humans are hyporesponsive to a CXCR3-ligand-mediated Th1 immunity-promoting loop.","volume":"18","author":"Campbell","year":"2004","journal-title":"FASEB J"},{"key":"2020071611552746000_R43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection.","volume":"193","author":"Hancock","year":"2001","journal-title":"J Exp Med"},{"key":"2020071611552746000_R44","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-\u03b3-inducible protein 10 (IP-10;CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"2020071611552746000_R45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","article-title":"CXCR3-mediated opposite effects of CXCL10 and CXCL4 on Th1 or Th2 cytokine production.","volume":"116","author":"Romagnani","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2020071611552746000_R46","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.99-0963com","article-title":"Differential expression and responsiveness of chemokine receptors (CXCR1\u20133) by human microvascular endothelial cells and umbilical vein endothelial cells.","volume":"14","author":"Salcedo","year":"2000","journal-title":"FASEB J"},{"key":"2020071611552746000_R47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2990.2001.00312.x","article-title":"CXCR3 expression in human central nervous system diseases.","volume":"27","author":"Goldberg","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2020071611552746000_R48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/60.1.25","article-title":"Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain.","volume":"60","author":"Van Der Meer","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"2020071611552746000_R49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.176.3.1456","article-title":"CXCR3\/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.","volume":"176","author":"Pan","year":"2006","journal-title":"J Immunol"},{"key":"2020071611552746000_R50","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2004.01.010","article-title":"The angiostatic activity of interferon-inducible protein-10\/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan.","volume":"9","author":"Yang","year":"2004","journal-title":"Mol Ther"},{"key":"2020071611552746000_R51","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/pros.20476","article-title":"Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.","volume":"66","author":"Shen","year":"2006","journal-title":"Prostate"},{"key":"2020071611552746000_R52","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)65699-4","article-title":"Chemokines IL-8, GRO\u03b1, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing.","volume":"153","author":"Engelhardt","year":"1998","journal-title":"Am J Pathol"},{"key":"2020071611552746000_R53","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archopht.116.12.1597","article-title":"Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy.","volume":"116","author":"Elner","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"2020071611552746000_R54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jir.2005.25.547","article-title":"Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects.","volume":"25","author":"Antonelli","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"2020071611552746000_R55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cyto.2006.03.012","article-title":"Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing.","volume":"34","author":"Antonelli","year":"2006","journal-title":"Cytokine"},{"key":"2020071611552746000_R56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.me.44.020193.002223","article-title":"Aging: causes and defenses.","volume":"44","author":"Martin","year":"1993","journal-title":"Annu Rev Med"},{"key":"2020071611552746000_R57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus.","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"key":"2020071611552746000_R58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.1997.tb01023.x","article-title":"From naive to effector-alterations with aging.","volume":"160","author":"Linton","year":"1997","journal-title":"Immunol Rev"},{"key":"2020071611552746000_R59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0047-6374(00)00200-1","article-title":"Chemokine production by peripheral blood mononuclear cells in elderly subjects.","volume":"121","author":"Pulsatelli","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"2020071611552746000_R60","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.158.11.5536","article-title":"Expression of IFN-inducible protein-10 in chronic hepatitis.","volume":"158","author":"Narumi","year":"1997","journal-title":"J Immunol"},{"key":"2020071611552746000_R61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","article-title":"Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.","volume":"123","author":"Nishioji","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2893.2001.00309.x","article-title":"Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels.","volume":"8","author":"Itoh","year":"2001","journal-title":"J Viral Hepat"},{"key":"2020071611552746000_R63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2036.2004.01872.x","article-title":"Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy.","volume":"19","author":"Apolinario","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2020071611552746000_R64","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2005-01-0126","article-title":"Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.","volume":"106","author":"Butera","year":"2005","journal-title":"Blood"},{"key":"2020071611552746000_R65","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection.","volume":"192","author":"Hancock","year":"2000","journal-title":"J Exp Med"},{"key":"2020071611552746000_R66","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.4049\/jimmunol.168.7.3205","article-title":"Donor T cell activation initiates small bowel allograft rejection through an IFN-\u03b3-inducible protein-10-dependent mechanism.","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"2020071611552746000_R67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/ajkd.2001.22076","article-title":"Expression of chemokines and chemokine receptors during human renal transplant rejection.","volume":"37","author":"Segerer","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2020071611552746000_R68","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64126-0","article-title":"CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.","volume":"158","author":"Agostini","year":"2001","journal-title":"Am J Pathol"},{"key":"2020071611552746000_R69","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/hc4601.098010","article-title":"Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.","volume":"104","author":"Melter","year":"2001","journal-title":"Circulation"},{"key":"2020071611552746000_R70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00007890-200301150-00013","article-title":"Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.","volume":"75","author":"Fahmy","year":"2003","journal-title":"Transplantation"},{"key":"2020071611552746000_R71","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1034\/j.1600-6143.2003.00151.x","article-title":"Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy.","volume":"3","author":"Akalin","year":"2003","journal-title":"Am J Transplant"},{"key":"2020071611552746000_R72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood.V97.3.601","article-title":"Interferon-inducible protein 10, monokine induced by interferon \u03b3, and interferon-inducible T-cell \u03b1 chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) \u03b1\u03b2+ CD8+ single-positive T cells, TCR\u03b3\u03b4+ T cells, and natural killer-type cells in human thymus.","volume":"97","author":"Romagnani","year":"2001","journal-title":"Blood"},{"key":"2020071611552746000_R73","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.194.9.1375","article-title":"Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment.","volume":"194","author":"Janatpour","year":"2001","journal-title":"J Exp Med"},{"key":"2020071611552746000_R74","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.167.4.1862","article-title":"Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells.","volume":"167","author":"Penna","year":"2001","journal-title":"J Immunol"},{"key":"2020071611552746000_R75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","article-title":"The biology of chemokines and their receptors.","volume":"18","author":"Rossi","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"2020071611552746000_R76","doi-asserted-by":"crossref","first-page":"24286","DOI":"10.1074\/jbc.271.39.24286","article-title":"Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response.","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071611552746000_R77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.V13153","article-title":"IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide.","volume":"13","author":"Romagnani","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2020071611552746000_R78","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1600-6143.2004.00525.x","article-title":"High pretransplant serum levels of CXCL10\/IP-10 are related to increased risk of allograft failure.","volume":"4","author":"Rotondi","year":"2004","journal-title":"Am J Transplant"},{"key":"2020071611552746000_R79","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000160759.85080.2E","article-title":"High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy.","volume":"79","author":"Lazzeri","year":"2005","journal-title":"Transplantation"},{"key":"2020071611552746000_R80","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-6143.2004.00354.x","article-title":"Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction.","volume":"4","author":"Hu","year":"2004","journal-title":"Am J Transplant"},{"key":"2020071611552746000_R81","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2004100836","article-title":"Prediction of acute renal allograft rejection by urinary monokine induced by IFN-\u03b3 (MIG).","volume":"16","author":"Hauser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2020071611552746000_R82","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/sj.ki.5000343","article-title":"Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function.","volume":"69","author":"Matz","year":"2006","journal-title":"Kidney Int"},{"key":"2020071611552746000_R83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","article-title":"Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system.","volume":"127","author":"Sorensen","year":"2002","journal-title":"J Neuroimmunol"},{"key":"2020071611552746000_R84","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1\u03b1 and IP-10 are expressed in demyelinating brain lesions.","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611552746000_R85","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.","volume":"103","author":"Sorensen","year":"1999","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R86","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4049\/jimmunol.160.1.444","article-title":"CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.","volume":"160","author":"Biddison","year":"1998","journal-title":"J Immunol"},{"key":"2020071611552746000_R87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1468-1331.2001.00327.x","article-title":"Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.","volume":"8","author":"Sorensen","year":"2001","journal-title":"Eur J Neurol"},{"key":"2020071611552746000_R88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-5728(01)00261-2","article-title":"Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies.","volume":"115","author":"Franciotta","year":"2001","journal-title":"J Neuroimmunol"},{"key":"2020071611552746000_R89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc1929","article-title":"Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.","volume":"6","author":"Muller","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2020071611552746000_R90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.2006.01005.x","article-title":"Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?","volume":"61","author":"Romagnani","year":"2006","journal-title":"Allergy"},{"key":"2020071611552746000_R91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage.","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2020071611552746000_R92","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2222.2006.02606.x","article-title":"Regulation of the T cell response.","volume":"36","author":"Romagnani","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"2020071611552746000_R93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage.","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"2020071611552746000_R94","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties.","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"key":"2020071611552746000_R95","first-page":"788","article-title":"Autoimmune thyroid disease: further developments in our understanding.","volume":"15","author":"Weetman","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071611552746000_R96","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease.","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"2020071611552746000_R97","first-page":"1995","author":"Marino","year":"2006"},{"key":"2020071611552746000_R98","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis.","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071611552746000_R99","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0901-769","article-title":"Determinants of autoimmune thyroid disease.","volume":"2","author":"Weetman","year":"2001","journal-title":"Nat Immunol"},{"key":"2020071611552746000_R100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI14321","article-title":"Thyroid autoimmunity.","volume":"108","author":"Rapoport","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.1994.4.333","article-title":"The pathology of autoimmune thyroid disease: a review.","volume":"4","author":"Livolsi","year":"1994","journal-title":"Thyroid"},{"key":"2020071611552746000_R102","first-page":"187","article-title":"The pathophysiology of autoimmune thyroid disease.","volume":"25","author":"Volpe","year":"1991","journal-title":"Endocr Regul"},{"key":"2020071611552746000_R103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08916939308993320","article-title":"Amplification by polymerase chain reaction of immunoglobulin heavy and light chain genes from orbital tissue of patients with Graves\u2019 ophthalmopathy.","volume":"16","author":"McLachlan","year":"1993","journal-title":"Autoimmunity"},{"key":"2020071611552746000_R104","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases.","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2020071611552746000_R105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(94)92029-X","article-title":"Leukocyte-endothelial interactions and regulation of leukocyte migration.","volume":"343","author":"Adams","year":"1998","journal-title":"Lancet"},{"key":"2020071611552746000_R106","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"2020071611552746000_R107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis.","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"2020071611552746000_R108","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/eji.1830241034","article-title":"Adhesion molecules from the LFA-1\/ICAM-1,3 and VLA-4\/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves\u2019 and Hashimoto\u2019s thyroid glands.","volume":"24","author":"Marazuela","year":"1994","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R109","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0090-1229(88)90073-6","article-title":"Immunohistochemical analysis of intrathyroidal lymphocytes in Graves\u2019 disease: evidence of activated T cells and production of interferon-\u03b3.","volume":"47","author":"Margolick","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"2020071611552746000_R110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0022-1759(92)90177-U","article-title":"In situ hybridization of the mRNA for interferon-\u03b3, interferon-\u03b1, interferon-\u03b2, interleukin-1\u03b2 and interleukin-6 and characterisation of infiltrating cells in thyroid tissues.","volume":"148","author":"Rutenfranz","year":"1992","journal-title":"J Immunol Method"},{"key":"2020071611552746000_R111","first-page":"309","article-title":"Intrathyroidal cytokine expression profiles in autoimmune thyroiditis.","volume":"141","author":"Paschke","year":"1994","journal-title":"J Immunol"},{"key":"2020071611552746000_R112","first-page":"355","article-title":"Analysis of cytokine gene expression in Graves\u2019 disease and multinodular goitre.","volume":"79","author":"Watson","year":"1994","journal-title":"Clin Endocrinol Metab"},{"key":"2020071611552746000_R113","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2249.1996.d01-784.x","article-title":"Intra-thyroidal cytokine gene expression in Hashimoto\u2019s thyroiditis.","volume":"105","author":"Ajjan","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R114","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/eji.1830271228","article-title":"Single cell analysis of intra-thyroidal lymphocytes shows differential cytokine expression in Hashimoto\u2019s and Graves\u2019 disease.","volume":"27","author":"Roura-Mir","year":"1997","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0950-351X(97)80708-2","article-title":"Cytokines and Graves\u2019 disease.","volume":"11","author":"Weetman","year":"1997","journal-title":"Bailliere Clin Endocrinol Metab"},{"key":"2020071611552746000_R116","first-page":"324","article-title":"Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1\u03b1 and interleukin-6.","volume":"77","author":"Grubeck-Lobenstein","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R117","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/jcem-69-4-738","article-title":"Demonstration of interleukin-1\u03b2 on perifollicular endothelial cells in the thyroid cells of patients with Graves\u2019 disease.","volume":"69","author":"Miyazaki","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2249.1991.tb05634.x","article-title":"Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods.","volume":"83","author":"Zheng","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/08916939509001930","article-title":"Immunocytochemical localisation of interleukin-1\u03b1 and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders.","volume":"20","author":"Kayser","year":"1995","journal-title":"Autoimmunity"},{"key":"2020071611552746000_R120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/jme.0.0150011","article-title":"Semi-quantitative analysis of interleukin-1\u03b1, interleukin-6 and interleukin-8 mRNA expression by human thyrocytes.","volume":"15","author":"Watson","year":"1995","journal-title":"J Mol Endocrinol"},{"key":"2020071611552746000_R121","first-page":"328","article-title":"Thyroid follicular cells produce interleukin-8.","volume":"75","author":"Weetman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-5793(96)00935-0","article-title":"Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes.","volume":"394","author":"Kasai","year":"1996","journal-title":"FEBS Lett"},{"key":"2020071611552746000_R123","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","article-title":"Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.","volume":"86","author":"Garcia\u0300-Lo\u0300pez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and Mig\/CXCL9 in the thyroid and increased serum levels of IP-10\/CXCL10 in the serum of subjects with recent onset Graves\u2019 disease.","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"2020071611552746000_R125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2249.2002.01778.x","article-title":"Graves\u2019 disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes.","volume":"127","author":"Aust","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","article-title":"Detection and localization of chemokine gene expression in autoimmune thyroid disease.","volume":"59","author":"Kemp","year":"2003","journal-title":"Clin Endocrinol"},{"key":"2020071611552746000_R127","first-page":"2873","article-title":"A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves\u2019 disease glands.","volume":"84","author":"Ashhab","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R128","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1210\/jc.2004-0977","article-title":"High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism.","volume":"89","author":"Antonelli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/eje.1.01847","article-title":"Increase of interferon-\u03b3 inducible \u03b1 chemokine CXCL10 but not \u03b2 32 chemokine CCL2 serum levels in chronic autoimmune thyroiditis.","volume":"152","author":"Antonelli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071611552746000_R130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves\u2019 disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071611552746000_R131","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.5401","article-title":"Increase of interferon-\u03b3 inducible \u03b1 chemokine CXCL10 serum levels in patients with active Graves\u2019 disease, and modulation by methimazole therapy and thyroidectomy.","volume":"93","author":"Antonelli","year":"2006","journal-title":"Br J Surg"},{"key":"2020071611552746000_R132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2006.02447.x","article-title":"Increase of interferon-\u03b3-inducible CXC chemokine CXCL10 serum levels in patients with active Graves\u2019 disease, and modulation by methimazole therapy.","volume":"64","author":"Antonelli","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R133","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V92.8.2668","article-title":"Divergent effects of interleukin-4 and interferon-\u03b3 on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses.","volume":"92","author":"Bonecchi","year":"1998","journal-title":"Blood"},{"key":"2020071611552746000_R134","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/1521-4141(200001)30:1<204::AID-IMMU204>3.0.CO;2-G","article-title":"Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines.","volume":"30","author":"Galli","year":"2000","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R135","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI118164","article-title":"Stimulation by thyroid-stimulating hormone and Graves\u2019 immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.","volume":"96","author":"Sato","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R136","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen.","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"2020071611552746000_R137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/thy.1994.4.145","article-title":"The immunomodulatory effects of antithyroid drugs.","volume":"4","author":"Weetman","year":"1994","journal-title":"Thyroid"},{"key":"2020071611552746000_R138","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198411223112106","article-title":"Antithyroid drugs.","volume":"311","author":"Cooper","year":"1984","journal-title":"N Engl J Med"},{"key":"2020071611552746000_R139","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.1984.tb03456.x","article-title":"Evidence for an effect of antithyroid drugs on the natural history of Graves\u2019 disease.","author":"Weetman","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0140-6736(92)92171-B","article-title":"Anti-thyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells.","volume":"340","author":"Weetman","year":"1992","journal-title":"Lancet"},{"key":"2020071611552746000_R141","first-page":"498","article-title":"Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.","volume":"72","author":"Mahad","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071611552746000_R142","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves\u2019 disease.","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R143","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.","volume":"7","author":"Delgado","year":"2001","journal-title":"Nat Med"},{"key":"2020071611552746000_R144","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"2020071611552746000_R145","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nm0896-899","article-title":"Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity.","volume":"2","author":"Waisman","year":"1996","journal-title":"Nat Med"},{"key":"2020071611552746000_R146","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/01.ASN.0000086473.23379.25","article-title":"Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB\/MpJ-Yaa genetic background.","volume":"14","author":"Yoh","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020071611552746000_R147","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat Med"},{"key":"2020071611552746000_R148","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2005-01-0410","article-title":"Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.","volume":"106","author":"Hubbard","year":"2005","journal-title":"Blood"},{"key":"2020071611552746000_R149","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2004.04.012","article-title":"Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon \u03b2-1b.","volume":"222","author":"Ochi","year":"2004","journal-title":"J Neurol Sci"},{"key":"2020071611552746000_R150","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","article-title":"Iodine-131 given for therapeutic purposes modulates differently interferon-\u03b3 inducible \u03b1 chemokine CXCL10 serum levels in patients with active Graves\u2019 disease or with toxic nodular goiter.","volume":"92","author":"Antonelli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R151","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2002.01629.x","article-title":"Serum concentrations of tumour necrosis factor-\u03b1 (TNF-\u03b1) and soluble TNF-\u03b1 receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.","volume":"57","author":"Diez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R152","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.0.1430197","article-title":"Serum concentrations of proinflammatory cytokines in Graves\u2019 disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.","volume":"143","author":"Salvi","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071611552746000_R153","first-page":"58","article-title":"Proinflammatory cytokine levels in hyperthyroidism.","volume":"26","author":"Senturk","year":"2003","journal-title":"Clin Invest Med"},{"key":"2020071611552746000_R154","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-\u03b3-inducible \u03b1-chemokine CXCL10 involvement in Graves\u2019 ophthalmopathy: modulation by peroxisome proliferator-activated receptor-\u03b3 agonists.","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R155","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach.","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"2020071611552746000_R156","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/thy.1997.7.579","article-title":"Intravenous immunoglobulin versus corticosteroid in treatment of Graves\u2019 ophthalmopathy.","volume":"7","author":"Baschieri","year":"1997","journal-title":"Thyroid"},{"key":"2020071611552746000_R157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0029-1211053","article-title":"The autoimmune infiltrate of Basedow\u2019s disease: analysis of clonal level and comparison with Hashimoto\u2019s thyroiditis.","volume":"97","author":"Mariotti","year":"1991","journal-title":"Exp Clin Endocrinol"},{"key":"2020071611552746000_R158","first-page":"1120","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy.","volume":"77","author":"De Carli","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R159","first-page":"1194","article-title":"Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy.","volume":"85","author":"Hiromatsu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients.","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R161","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2249.2000.01335.x","article-title":"Both Th1- and Th2-derived cytokines in serum are elevated in Graves\u2019 ophthalmopathy.","volume":"121","author":"Wakelkamp","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R162","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00613.x","article-title":"Analysis of orbital T cells in thyroid-associated ophthalmopathy.","volume":"112","author":"Forster","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R163","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor- activators inhibit IFN-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.","volume":"164","author":"Marx","year":"2000","journal-title":"J Immunol"},{"key":"2020071611552746000_R164","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1440-1711.2002.01062.x","article-title":"Recruitment of lymphocytes to the human liver.","volume":"80","author":"Lalor","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"2020071611552746000_R165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/jcem-72-1-209","article-title":"Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism.","volume":"72","author":"Marcocci","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R166","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1530\/eje.0.1420022","article-title":"Grey scale thyroid ultrasonography in the evaluation of patients with Graves\u2019 disease.","volume":"142","author":"Vitti","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2020071611552746000_R167","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.4049\/jimmunol.168.5.2470","article-title":"A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transform nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis.","volume":"168","author":"Wang","year":"2002","journal-title":"J Immunol"},{"key":"2020071611552746000_R168","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1073\/pnas.020522597","article-title":"Hypothyroidism in transgenic mice expressing IFN-\u03b3 in the thyroid.","volume":"97","author":"Caturegli","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611552746000_R169","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexmp.2004.08.004","article-title":"Early chemokine expression induced by interferon-\u03b3 in a murine model of Hashimoto\u2019s thyroiditis.","volume":"77","author":"Kimura","year":"2004","journal-title":"Exp Mol Pathol"},{"key":"2020071611552746000_R170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri750","article-title":"Autoimmune thyroid disease: new models of cell death in autoimmunity.","volume":"2","author":"Stassi","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2020071611552746000_R171","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03345149","article-title":"Role for interferon-\u03b3 inducible chemokines in endocrine autoimmunity: an expanding field.","volume":"26","author":"Rotondi","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"2020071611552746000_R172","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/thy.1994.4.493","article-title":"The potential immunological role of the thyroid cell in autoimmune thyroid disease.","volume":"4","author":"Weetman","year":"1994","journal-title":"Thyroid"},{"key":"2020071611552746000_R173","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/meta.2002.34717","article-title":"Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.","volume":"51","author":"Kokkotou","year":"2002","journal-title":"Metabolism"},{"key":"2020071611552746000_R174","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.187.4.601","article-title":"Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice.","volume":"187","author":"Lu","year":"1998","journal-title":"J Exp Med"},{"key":"2020071611552746000_R175","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.153.11.4969","article-title":"C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.","volume":"153","author":"Maghazachi","year":"1994","journal-title":"J Immunol"},{"key":"2020071611552746000_R176","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/eji.1830260207","article-title":"CC chemokines induce the generation of killer cells from CD56+ cells.","volume":"26","author":"Maghazachi","year":"1996","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R177","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.155.8.3877","article-title":"\u03b1 And \u03b2 chemokines induce NK cell migration and enhance NK-mediated cytolysis.","volume":"155","author":"Taub","year":"1995","journal-title":"J Immunol"},{"key":"2020071611552746000_R178","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.4049\/jimmunol.158.9.4129","article-title":"Differential CC chemokine-induced enhancement of T helper cell cytokine production.","volume":"158","author":"Karpus","year":"1997","journal-title":"J Immunol"},{"key":"2020071611552746000_R179","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/107999099313127","article-title":"Increase in circulating levels of monocyte chemoattractant protein-1 with aging.","volume":"19","author":"Inadera","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"2020071611552746000_R180","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/1521-4141(2002012)32:12<3435::AID-IMMU3435>3.0.CO;2-O","article-title":"Chemokines modulate experimental autoimmune thyroiditis through attraction of auto-reactive or regulatory T cells.","volume":"32","author":"Goulvestre","year":"2002","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R181","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"\u03b2 Cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat Med"},{"key":"2020071611552746000_R182","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","article-title":"Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice.","volume":"65","author":"Ohashi","year":"1991","journal-title":"Cell"},{"key":"2020071611552746000_R183","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"2020071611552746000_R184","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.","volume":"1","author":"von Herrath","year":"1994","journal-title":"Immunity"},{"key":"2020071611552746000_R185","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/diabetes.49.11.1801","article-title":"Virus-induced autoimmune diabetes: most \u03b2-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) CTL.","volume":"49","author":"Seewaldt","year":"2000","journal-title":"Diabetes"},{"key":"2020071611552746000_R186","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.4049\/jimmunol.166.12.7023","article-title":"A dual role for TNF-\u03b1 in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis.","volume":"166","author":"Christen","year":"2001","journal-title":"J Immunol"},{"key":"2020071611552746000_R187","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.4049\/jimmunol.171.12.6838","article-title":"Among CXCR3 chemokines, IFN-\u03b3-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-\u03b3 (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.","volume":"171","author":"Christen","year":"2003","journal-title":"J Immunol"},{"key":"2020071611552746000_R188","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4049\/jimmunol.173.11.7017","article-title":"CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced \u03b2 cell proliferation without affecting insulitis.","volume":"173","author":"Morimoto","year":"2004","journal-title":"J Immunol"},{"key":"2020071611552746000_R189","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.","volume":"101","author":"Qin","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/08916930410001713124","article-title":"IP-10 and type 1 diabetes: a question of time and location.","volume":"37","author":"Christen","year":"2004","journal-title":"Autoimmunity"},{"key":"2020071611552746000_R191","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.24.3.510","article-title":"Elevated serum IP-10 levels observed in type 1 diabetes.","volume":"24","author":"Shimada","year":"2001","journal-title":"Diabetes Care"},{"key":"2020071611552746000_R192","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","article-title":"Serum concentrations of the interferon-\u03b3-inducible chemokine IP-10\/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease.","volume":"45","author":"Nicoletti","year":"2002","journal-title":"Diabetologia"},{"key":"2020071611552746000_R193","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00125-003-1134-4","article-title":"Serum concentrations of the interferon-inducible chemokine IP-10\/CXCL10 are augmented in both newly-diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease.","volume":"46","author":"Rotondi","year":"2003","journal-title":"Diabetologia"},{"key":"2020071611552746000_R194","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2337\/diab.42.2.359","article-title":"Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.","volume":"42","author":"Tuomi","year":"1993","journal-title":"Diabetes"},{"key":"2020071611552746000_R195","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/diacare.16.5.780","article-title":"Immunogenetic and clinical characterization of slowly progressive IDDM.","volume":"16","author":"Kobayashi","year":"1993","journal-title":"Diabetes Care"},{"key":"2020071611552746000_R196","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.4049\/jimmunol.162.8.4928","article-title":"Gene expression and production of the monokine induced by IFN-\u03b3 (MIG), IFN-inducible T cell chemoattractant (I-TAC), and IFN-inducible protein-10 (IP-10) chemokines by human neutrophils.","volume":"162","author":"Gasperini","year":"1999","journal-title":"J Immunol"},{"key":"2020071611552746000_R197","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0006-2952(97)00492-9","article-title":"Cytokines and their roles in pancreatic islet \u03b2-cell destruction and insulin-dependent diabetes mellitus.","volume":"55","author":"Rabinovitch","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"2020071611552746000_R198","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diabetes.52.5.1137","article-title":"An association of autoantibody status and serum cytokine levels in type 1 diabetes.","volume":"52","author":"Hanifi-Moghaddam","year":"2003","journal-title":"Diabetes"},{"key":"2020071611552746000_R199","first-page":"120","article-title":"Incidence of IDDM in the 0\u201329 yrs age-group in Umbria, Italy.","volume":"10","author":"Picchio","year":"1997","journal-title":"Diabetes Nutr Metab"},{"key":"2020071611552746000_R200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2005.09.027","article-title":"Significance of serum CXCL10\/IP-10 level in type 1 diabetes.","volume":"26","author":"Shigihara","year":"2006","journal-title":"J Autoimmun"},{"key":"2020071611552746000_R201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/JPEM.1996.9.S1.89","article-title":"IDDM and autoimmune thyroid disease in the paediatric age group.","volume":"9","author":"Lorini","year":"1996","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071611552746000_R202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2000.00983.x","article-title":"Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.","volume":"52","author":"Gambelunghe","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R203","first-page":"2909","article-title":"Clinical review 130: Addison\u2019s disease.","volume":"86","author":"Ten","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R204","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071611552746000_R205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1043-2760(00)00283-6","article-title":"Adrenal autoimmunity: results and developments.","volume":"11","author":"Peterson","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2020071611552746000_R206","first-page":"750","article-title":"Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison\u2019s disease: a reexamination.","volume":"77","author":"Wardle","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R207","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/jcem.87.2.8192","article-title":"Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.","volume":"87","author":"Myhre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R208","first-page":"149","author":"Volpe\u0301","year":"1981"},{"key":"2020071611552746000_R209","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/08916939209146129","article-title":"Experimental autoimmune adrenalitis: a murine model for Addison\u2019s disease.","volume":"12","author":"Fujii","year":"1992","journal-title":"Autoimmunity"},{"key":"2020071611552746000_R210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2249.1992.tb03073.x","article-title":"T and B cell reactivity to adrenal antigens in autoimmune Addison\u2019s disease.","volume":"88","author":"Freeman","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2020071611552746000_R211","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1210\/jc.2004-1062","article-title":"Elevated serum interferon-\u03b3-inducible chemokine-10\/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.","volume":"90","author":"Rotondi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R212","first-page":"1002","article-title":"Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.","volume":"76","author":"De Bellis","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R213","first-page":"3507","article-title":"Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison\u2019s disease.","volume":"83","author":"Laureti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R214","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2265.2000.01050.x","article-title":"Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison\u2019s disease.","volume":"53","author":"Laureti","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611552746000_R215","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.2003-030954","article-title":"Italian Addison Network Study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.","volume":"89","author":"Falorni","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R216","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0952-7915(03)00103-1","article-title":"Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression.","volume":"15","author":"Hancock","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"2020071611552746000_R217","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X","article-title":"Peroxisome proliferator-activated receptor activators affect the maturation of human monocyte-derived dendritic cells.","volume":"31","author":"Gosset","year":"2001","journal-title":"Eur J Immunol"},{"key":"2020071611552746000_R218","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.MIB.0000160770.94199.9b","article-title":"Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms.","volume":"11","author":"Schaefer","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2020071611552746000_R219","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1152\/ajpcell.2000.279.6.C1859","article-title":"15-Deoxy-12,14-prostaglandin J2 facilitates thyroglobulin production by cultured human thyrocytes.","volume":"279","author":"Kasai","year":"2000","journal-title":"Am J Physiol"},{"key":"2020071611552746000_R220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/105072503322401032","article-title":"Peroxisome proliferator-activated receptor-\u03b3 gene expression in orbital adipose\/connective tissues is increased during the active stage of Graves\u2019 ophthalmopathy.","volume":"13","author":"Mimura","year":"2003","journal-title":"Thyroid"},{"key":"2020071611552746000_R221","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.4049\/jimmunol.172.9.5790","article-title":"Peroxisome proliferator-activated receptor \u03b1 agonists as therapy for autoimmune disease.","volume":"172","author":"Lovett-Racke","year":"2004","journal-title":"J Immunol"},{"key":"2020071611552746000_R222","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI7145","article-title":"A novel therapy for colitis utilizing PPAR-\u03b3 ligands to inhibit the epithelial inflammatory response.","volume":"104","author":"Su","year":"1999","journal-title":"J Clin Invest"},{"key":"2020071611552746000_R223","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"2020071611552746000_R224","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(00)81177-0","article-title":"New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?","volume":"93","author":"Karin","year":"1998","journal-title":"Cell"},{"key":"2020071611552746000_R225","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4049\/jimmunol.164.4.1768","article-title":"Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes.","volume":"164","author":"Franchimont","year":"2000","journal-title":"J Immunol"},{"key":"2020071611552746000_R226","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-\u03b3 signaling by glucocorticoids.","volume":"170","author":"Hu","year":"2003","journal-title":"J Immunol"},{"key":"2020071611552746000_R227","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Clinical review 169: interferon-\u03b1-related thyroid disease: pathophysiological, epidemiological, and clinical aspects.","volume":"89","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611552746000_R228","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/BF03348040","article-title":"Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-\u03b2 therapy for multiple sclerosis.","volume":"21","author":"Rotondi","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071611552746000_R229","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/edrv.22.5.0441","article-title":"Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care.","volume":"22","author":"Muller","year":"2001","journal-title":"Endocr Rev"},{"key":"2020071611552746000_R230","first-page":"769","author":"Girotra","year":"2006"},{"key":"2020071611552746000_R231","first-page":"1979","author":"Weetman","year":"2006"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/28\/5\/492\/10335474\/edrv0492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/28\/5\/492\/10335474\/edrv0492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:25:54Z","timestamp":1737350754000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/28\/5\/492\/2355002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":231,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2006-0044","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}